A prospective randomized study comparing high- and low-dose leucovorin combined with same-dose 5-fluorouracil in advanced colorectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 3, 1998, Pages 233-236

  Ychou, Marc ^a   Fabbro Peray, Pascale ^b   Perney, Pascal ^b   Marçais, Olivier ^a   Gouze, Christian ^b   Ribard, Didier ^c   Bons Rosset, Françoise ^c   Heran, Bernard ^d   Veyrac, Michel ^b   Blanc, François ^b  

^a CENTRE VAL D AURELLE   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d CHR Perpignan   (France)

Author keywords

Chemotherapy; Colorectal cancer; Leucovorin; Randomized study

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TREATMENT OUTCOME; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031865260     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199806000-00004     Document Type: Article

References (15)

1. Laufman LR, Krzeczowski KA, Roach R, et al. Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer. J Clin Oncol 1987;5:1394.
2. Machover D, Goldschmidt E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1986;4:685.
3. Doroshow JH, Multhauf P, Leong L, et al. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990;8:491.
4. Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469.
5. Laufman LR, Wayne D, Brenckman S Jr, et al. Clinical experience with leucovorin and 5-fluorouracil. Cancer 1989;63:1031.
6. Petrelli N, Douglass HO, Lemuel Herrera JR, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 1989;7:1419.
7. Poon MA, O'Connell MJ, Moertal CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989;7:407.
8. Valone FH, Friedman MA, Wittlinger PS, et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. J Clin Oncol 1989;7:1427.
9. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
10. Poon MA, O'Connell MJ, Wieand HS, et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991;9:1967.
11. Miller AB, Hoogstratten B, Staquet M. Reporting results of cancer treatment. Cancer 1981;47:2507.
12. Com Nougué C, Rodary C. Méthodes statistiques pour mettre en évidence l'équivalence de deux traitements. Rev Epidemiol Santé Publique 1987;35:416-9.
13. Com Nougué C, Rey A, Ducourtieux M, Rodary C. Problèmes posés par la recherche de l'équivalence de deux distributions de survie. Rev Epidmiol Santé Publique 1995;43:84.
14. Valsecchi R, Labiance R, Cascinu S, et al. High dose (HD) versus low dose (LD) L-leucovorin (LLV) as a modulator of 5-day 5-fluorouracil (5FU) in advanced colorectal cancer (ACC): a "GISCAD" phase III study. Proceedings of American Society of Clinical Oncology 1995;14:A457.
15. De Gramont A, Bosset JF, Milan C, et al. A prospectively randomized trial comparing 5FU bolus with low dose folinic acid (FUFOLld) and 5FU bolus plus continuous infusion with high dose folinic acid (LV5FU2) for advanced colorectal cancer [Abstract]. Proceedings of the American Society of Clinical Oncology 1995;14:A455.